CYP17A1

CYP17A1gene

CYP17A1 genetic variants modulate lipid metabolism and atherosclerosis susceptibility through altered steroid and lipid synthesis.

Pathway placement

Cascade stepOff-pathway / systemic markers

Confidencemedium

RationaleSteroidogenic enzyme; atherosclerosis susceptibility locus; lipid metabolism regulation.

Druggability

DruggableYes

Known drugs / candidates6

Small-molecule tractableYes

Antibody tractableNo

EnsemblENSG00000148795

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.

Specimen

Whole blood — gene is not a circulating analyte; measure protein product or genotype

Collection tube

K2-EDTA whole blood (lavender-top)

Method / principle

SNP genotyping / sequencing; or immunoassay of encoded protein

Reagent / substrate

Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein

Platform

qPCR / NGS / array

Turnaround · availability

Send-out · Genotyping widely available; protein assay variable

GWAS associations

Traits: myocardial infarction